Suicide and schizophrenia: Clozapine and the InterSePT study

Journal of Clinical Psychiatry

Volumn 60, Issue SUPPL. 12, 1999, Pages 47-50

  Meltzer, Herbert Y ^a  

^a VANDERBILT UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CLOZAPINE; HALOPERIDOL; OLANZAPINE;

CHOLINERGIC SYSTEM; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOPAMINERGIC SYSTEM; DRUG EFFECT; HUMAN; LEUKOCYTE; MAJOR CLINICAL STUDY; NORADRENERGIC SYSTEM; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; REVIEW; RISK ASSESSMENT; SCHIZOPHRENIA; SEROTONINERGIC SYSTEM; SUICIDE; TREATMENT OUTCOME;

AGRANULOCYTOSIS; ANTIPSYCHOTIC AGENTS; CLINICAL TRIALS; CLOZAPINE; DRUG RESISTANCE; HUMANS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SUICIDE; TREATMENT OUTCOME;

EID: 0033018989     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (29)

1. Bleuler E. Dementia praecox of the group of schizophrenias (1911). Zinkin J, trans. New York, NY: International Universities Press; 1950
2. Meltzer HY, Okayli G. Reduction of suicidality during clozapine treatment of neuroleptic-resistant schizophrenia: impact on risk-benefit assessment. Am J Psychiatry 1995;152:183-190
3. Axelsson R, Lagerkvist-Briggs M. Factors predicting suicide in psychotic patients. Eur Arch Psychiatry Clin Neurosci 1992;241:259-266
4. Cohen LJ, Test MA, Brown RL. Suicide and schizophrenia: data from a prospective community treatment study. Am J Psychiatry 1990;147: 602-607
5. Newman SC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry 1991;36:239-245
6. Ciompi L. Late suicide in former mental patients. Psychiatr Clin (Basel) 1976;9:59-63
7. Winokur G, Tsuang M. The Iowa 500: suicide in mania, depression and schizophrenia. Am J Psychiatry 1975;132:650-651
8. Solomon P. The admissions process in two state psychiatric hospitals. Hosp Community Psychiatry 1981;32:405-408
9. Hawton K, Fagg J. Suicide and other causes of death, following attempted suicide. Br J Psychiatry 1988;152:359-366
10. Krausz M, Müller-Thomsen T, Haasen C. Suicide among schizophrenic adolescents in the long-term course of illness. Psychopathology 1995;28: 95-103
11. Mortensen PB, Juel K. Mortality and causes of death in first admitted schizophrenic patients. Br J Psychiatry 1993;163:183-189
12. Nàhunek K, Rodovà A, Svestka J, et al. Clinical experience with clozapine in endogenous depression [letter]. Activ Nerv Super (Praha) 1973;15:102
13. Ranjan R, Meltzer HY. Acute and long term effectiveness of clozapine in treatment-resistant psychotic depression. Biol Psychiatry 1996;40: 253-258
14. Calabrese JR, Kimmel SE, Woyshville MJ, et al. Clozapine for treatment-refractory mania. Am J Psychiatry 1996;153:759-764
15. Suppes T, McElroy SL, Gilbert J, et al. Clozapine in the treatment of dysphoric mania. Biol Psychiatry 1992;32:270-280
16. Naber D, Hippius H. The European experience with use of clozapine. Hosp Community Psychiatry 1990;41:886-890
17. Nahunek K, Svestka J, Misurec J, et al. Experiences with clozapine. Cesk Psychiatr 1975;41:886-890
18. Kane JM, Woerner MG, Pollack S, et al. Does clozapine cause tardive dyskinesia? J Clin Psychiatry 1993;54:327-330
19. Volavka J, Zito JM, Vitrai J, et al. Clozapine effects on hostility and aggression in schizophrenia. J Clin Psychopharmacol 1993;13:287-289
20. Buckley P, Thompson PA, Way L, et al. Substance abuse and clozapine treatment. J Clin Psychiatry 1994;55(9, suppl B):114-116
21. Hogan TP, Awad AG. Pharmacotherapy and suicide risk in schizophrenia. Can J Psychiatry 1983;28:277-281
22. Cohen LJ, Test MA, Brown RL. Suicide and schizophrenia: data from a prospective community treatment study. Am J Psychiatry 1990;147: 602-607
23. Walker AM, Lanza LL, Arellano F, et al. Mortality in current and former users of clozapine. Epidemiology 1997;8:671-677
24. Allebeck P. Schizophrenia: a life-shortening disease. Schizophr Bull 1989; 15:81-89
25. Anderson C, Connelly J, Johnstone EC, et al. Disabilities and circumstances of schizophrenic patients: a follow-up study: cause of death. Br J Psychiatry 1991;159:30-33
26. Berren MR, Hill KR, Merikle E, et al. Serious mental illness and mortality rates. Hosp Community Psychiatry 1994;45:604-605
27. Black DW, Winokur G. Age, mortality and chronic schizophrenia. Schizophr Res 1988;1:267-272
28. Newman SC, Bland RC. Mortality in a cohort of patients with schizophrenia: a record linkage study. Can J Psychiatry 1991;36:239-245
29. Tollefson GD, Sanger TM, Lu Y, et al. Depressive signs and symptoms in schizophrenia. Arch Gen Psychiatry 1998;55:250-258